mifepristone has been researched along with Adenomyosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, G; Li, Y; Ma, Q; Mu, Y; Song, S; Yang, L; Zhu, H | 1 |
| Che, X; Chen, Y; Dong, J; He, J; Lin, Q; Sun, W; Wang, J; Wang, Q; Wu, W; Xu, J; Xu, Z; Ye, L; Zhai, L; Zhang, J; Zhang, X; Zhao, W; Zhao, X; Zheng, F; Zheng, J; Zhou, J; Zhou, Y; Zhu, D; Zhu, W | 1 |
| Che, X; Chen, S; Guo, X; He, J; Li, T; Sun, W; Wang, J; Yu, Q; Zhang, X; Zou, G | 1 |
| Che, X; Guo, X; He, J; Li, T; Wang, J; Zhang, X | 1 |
| Li, C; Li, M; Qin, X; Sun, W; Wang, C; Zhang, H; Zhao, X | 1 |
| Jiang, X; Wang, S; Wang, Y | 1 |
| Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
1 review(s) available for mifepristone and Adenomyosis
| Article | Year |
|---|---|
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
3 trial(s) available for mifepristone and Adenomyosis
| Article | Year |
|---|---|
Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
Topics: Adenomyosis; Adult; CA-125 Antigen; Dysmenorrhea; Female; Humans; Mifepristone; Uterus | 2023 |
A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis.
Topics: Adenomyosis; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Survival; Endometrium; Epithelial Cells; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; Humans; Mifepristone; Mitochondria; Models, Biological; Receptors, CXCR4; Signal Transduction; Stromal Cells | 2020 |
The influence of mifepristone to caspase 3 expression in adenomyosis.
Topics: Adenomyosis; Adult; Caspase 3; Dose-Response Relationship, Drug; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Middle Aged; Mifepristone | 2014 |
3 other study(ies) available for mifepristone and Adenomyosis
| Article | Year |
|---|---|
Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Topics: Adenomyosis; Child; Dysmenorrhea; Female; High-Intensity Focused Ultrasound Ablation; Humans; Levonorgestrel; Mifepristone | 2023 |
The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea.
Topics: Adenomyosis; Cell Line; Cell Movement; Cells, Cultured; Dysmenorrhea; Enzyme-Linked Immunosorbent Assay; Female; Humans; Inflammation; Interleukin-6; Mast Cells; Mifepristone; Stromal Cells; Tumor Necrosis Factor-alpha | 2020 |
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
Topics: Adenomyosis; Adult; B7 Antigens; Endometrium; Female; Gene Expression; Hormone Antagonists; Humans; Immune Checkpoint Inhibitors; Inducible T-Cell Co-Stimulator Ligand; Middle Aged; Mifepristone; Programmed Cell Death 1 Ligand 2 Protein; V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 2021 |